How trial results are intended to be used: is PRECIS-2 a step forward?

Journal of Clinical Epidemiology

Volumn 84, Issue , 2017, Pages 25-26

  Dekkers, Olaf M ^a,b   Bossuyt, Patrick M ^c   Vandenbroucke, Jan P ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL PRACTICE; HUMAN; INTENSIVE CARE UNIT; LOW INCOME COUNTRY; NOTE; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; METHODOLOGY;

RESEARCH DESIGN;

EID: 84960413631     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.01.033     Document Type: Note

References (4)

1. Schwartz, D., Lellouch, J., Explanatory and pragmatic attitudes in therapeutical trials. J Clin Epidemiol 62 (2009), 499–505.
2. Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K.E., Zwarenstein, M., The PRECIS-2 tool: designing trials that are fit for purpose. BMJ, 350, 2015, h2147.
3. Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006), 449–461.
4. Dekkers, O.M., von Elm, E., Algra, A., Romijn, J.A., Vandenbroucke, J.P., How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 39 (2010), 89–94.